Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...

First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...

This press release is not intended for US or UK media. Ingelheim, Germany and Ridgefield, Conn. Boehringer Ingelheim today announced that The New England Journal of Medicine (NEJM) published results ...

Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...

The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...

Lung cancer is classified into non-small cell and small cell types, influencing treatment strategies and prognosis. Advances in targeted therapies, immunotherapy, and minimally invasive surgeries have ...

“Lung cancer, though common and serious, still has many misconceptions,” says Ian Bostock, MD, a thoracic surgeon at Miami Cancer Institute in Florida. “Clearing these myths helps patients and ...

The non-small cell lung cancer clinical trial analysis report delivers important insights into ongoing research of 120+ ...

Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...

You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical ...